Current Edition


Antares Pharma develops novel auto-injector devices for innovative combination products

With over 30 years of experience in drug device engineering, Antares Pharma has nurtured its R&D prowess and specialized in creating custom designed drug delivery …

Continue Reading →

AstraZeneca, Daiichi Sankyo build Enhertu’s blockbuster case with breast cancer win against Roche’s Kadcyla

AstraZeneca and Daiichi Sankyo’s Enhertu is shouldering big expectations. With a new head-to-head trial win against Roche’s Kadcyla, the companies are showing their antibody-drug conjugate …

Continue Reading →

Heptares and ICL sign gastrointestinal R&D pact

Heptares Therapeutics, the UK-headquartered wholly-owned subsidiary of Japan’s Sosei Group, has formed a new drug research and development pact with Imperial College London focused on …

Continue Reading →